Hypermobility: Beyond Loose Joints — hEDS, Fascia, Nervous System and Lymphatics

When most people think of hypermobility, they picture “double-jointed” party tricks or extreme yoga poses. But clinically, hypermobility is far more than just flexible joints — it’s a systemic connective tissue difference that affects the fascia, nervous system, proprioception, and even lymphatic circulation.

Understanding hypermobility requires zooming out from the joint itself and looking at the interconnected network of collagen, elastin, fascia, mechanoreceptors, and autonomic regulation that shapes how hypermobile bodies move, sense, and recover.

What Is Hypermobility? A Collagen-Based Perspective

At its core, hypermobility is linked to alterations in connective tissue structure, particularly collagen and elastin:

  • Collagen Types I and III: Type I provides tensile strength; Type III is more elastic. In hypermobility, the ratio often shifts toward more elastic tissue, increasing extensibility but reducing joint stability.

  • Extracellular Matrix (ECM) Dysregulation: Fibroblast activity and matrix metalloproteinases (MMPs) may be altered, affecting how collagen is formed and repaired, contributing to tissue fragility.

  • Result: Joints move beyond the physiological end range without the usual protective tension of ligaments and fascia, predisposing to injuries and chronic strain.

Fascia: The Body’s Sensory Web

Fascia is a living, innervated organ, dense with mechanoreceptors and nociceptors, making it integral to proprioception and pain signalling.

In hypermobility:

  • Reduced fascial stiffness: Leads to decreased structural support.

  • Altered mechanoreceptor feedback: The brain receives less precise proprioceptive input.

  • Muscle compensation: Chronic hypertonicity develops as muscles attempt to stabilize unstable joints, explaining why hypermobile individuals often feel simultaneously “too loose and too tight.”

Fascia is both a culprit and a compensator, influencing joint stability, movement patterns, and pain perception.

Nervous System: Proprioception and Autonomic Regulation

Proprioception is the brain’s ability to sense joint position, movement, and body orientation. Hypermobile individuals often experience:

  • Impaired joint position sense (JPS): The brain receives inaccurate signals from lax joints.

  • Motor control challenges: Clumsiness, poor fine motor skills, and higher injury risk.

  • Autonomic dysregulation: Many hypermobile individuals experience dysautonomia, including postural orthostatic tachycardia syndrome (POTS), due to:

    • Lax vessel walls → poor venous return

    • Inefficient baroreceptors → unstable blood pressure

    • Sympathetic overdrive → fatigue, dizziness, palpitations

The nervous system does more than “read joints”: it also manages cardiovascular tone, balance, and systemic responses to stress and movement.

The Lymphatic System: An Overlooked Connection

The lymphatic system relies on connective tissue and fascial support for optimal function. In hypermobility:

  • Reduced fascial support: Lymphatic vessels may lack the mechanical scaffolding needed for efficient flow.

  • Diaphragmatic dysfunction: Hypermobile individuals often breathe with accessory muscles rather than the diaphragm, reducing lymphatic propulsion.

  • Sympathetic dominance: Chronic stress can constrict lymphatic smooth muscle, slowing transport.

Consequences include:

  • Localized edema or heaviness

  • Slower recovery from exertion or illness

  • Immune dysregulation and increased inflammation

Hypermobility vs. hEDS — When It’s More Than Flexible Joints

While many people experience generalised joint hypermobility, hypermobile Ehlers–Danlos Syndrome (hEDS) is a hereditary connective tissue disorder representing the far end of the Hypermobility Spectrum.

Genetics and Collagen Function

  • No single gene mutation identified, but differences exist in fibroblast function, collagen fibrillogenesis, and ECM signalling, including TNXB and TGF-β pathways.

  • Effects: reduced collagen cross-linking, disorganized fibril architecture, and increased tissue compliance and fragility.

Systemic Manifestations

  • Dysautonomia (POTS)

  • Gastrointestinal dysmotility

  • Pelvic floor dysfunction and prolapse

  • Temporomandibular dysfunction and craniocervical instability

Fascial and Neurological Implications

  • Reduced fascial density → impaired mechanotransduction

  • Imprecise proprioceptive feedback → clumsiness, poor movement patterns

  • Chronic micro-injury → amplified nociception and central sensitisation

Lymphatic Implications

  • Lymphatic vessels may be too compliant, impairing flow

  • Venous pooling and low diaphragmatic tone exacerbate lymphatic stasis

  • Clinical consequences: edema, inflammation, slow recovery

Management and Clinical Approach

Effective management focuses on stability, regulation, and supportive interventions, not restricting movement:

Fascia & Proprioception:

  • Eccentric and isometric strengthening

  • Proprioceptive training: closed-chain exercises, unstable surfaces, eyes-closed drills

Nervous System:

  • Diaphragmatic breathing and vagal tone activation

  • Neuromotor retraining: Tai Chi, Feldenkrais, Pilates

Lymphatics:

  • Manual lymphatic drainage (MLD)

  • Rhythmic movement: walking, rebounding, swimming

  • Postural awareness to reduce pooling

Additional considerations: pacing, education, and gradual load progression to prevent injury.

Conclusion

Hypermobility is far more than loose joints. It is a systemic connective tissue variation affecting fascia, proprioception, the autonomic nervous system, and lymphatic circulation. Including hEDS provides a framework for understanding when hypermobility is part of a broader hereditary disorder.

By addressing fascial support, nervous system regulation, and lymphatic flow, individuals can enhance stability, reduce pain, and improve overall function, moving beyond the misconception that hypermobility is merely a “fun flexibility trick.”

References

  1. Castori, M., et al. (2017). A framework for the classification of joint hypermobility. Am J Med Genet C, 175(1), 148–157.

  2. Malfait, F., et al. (2017). The 2017 international classification of the Ehlers–Danlos syndromes. Am J Med Genet C, 175(1), 8–26.

  3. Schleip, R., et al. (2019). Fascial system research: A narrative review. J Bodyw Mov Ther, 23(4), 555–567.

  4. Rombaut, L., et al. (2010). Musculoskeletal complaints in hEDS. Disabil Rehabil, 32(16), 1339–1345.

  5. Russek, L. N., et al. (2019). Recognizing and managing hypermobility-related conditions. Physiother Pract Res, 40(1), 1–14.

  6. Chopra, P., & Tinkle, B. (2015). Pain management in EDS. Am J Med Genet C, 169(1), 84–96.

  7. Voermans, N. C., et al. (2011). Fatigue in EDS. Semin Arthritis Rheum, 40(3), 267–274.

  8. Levy, H. P. (2023). Ehlers–Danlos Syndrome, Hypermobility Type. GeneReviews.

Previous
Previous

“Well, You’re Around That Age…”

Next
Next

Learning Your Own Language Before Listening to Everyone Else